|
HY-10559-1mL
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P2185A-1mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-P2185A-10mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-P2185A-5mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-12522-10mg
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12522-100mg
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12522-25mg
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12522-5mg
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12522-50mg
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12522-1mL
|
MedChemexpress LLC
|
PF-06380101 [CAS 1436391-86-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-112434-5mg
|
MedChemexpress LLC
|
PF-06733804 [CAS 1873373-33-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-1mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-10mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-100mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-25mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-5mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-50mg
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112437-1mL
|
MedChemexpress LLC
|
PF-06737007 [CAS 1863905-38-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112436-10mg
|
MedChemexpress LLC
|
PF-6683324 [CAS 1799788-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112436-100mg
|
MedChemexpress LLC
|
PF-6683324 [CAS 1799788-94-5]
|
|
Neuroscience-Neuromodulation
|
|
